Scpharmaceuticals Stock Price, News & Analysis (NASDAQ:SCPH)

$15.35 +0.35 (+2.33 %)
(As of 02/25/2018 11:17 AM ET)
Previous Close$15.35
Today's Range$14.70 - $15.38
52-Week Range$11.50 - $18.17
Volume19,809 shs
Average Volume30,232 shs
Market Capitalization$270.31 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Scpharmaceuticals (NASDAQ:SCPH)

Scpharmaceuticals logoscPharmaceuticals, Inc., is a biopharmaceutical company. The Company is engaged in developing pharmaceutical products for subcutaneous delivery. The Company offers sc2Wear Infusor, which is a small pump that attaches to the body using a standard medical adhesive. The sc2Wear Infusor injects the drug into the body slowly, similar to an intravenous (IV) drip. The Company's products administered subcutaneously through the sc2Wear Infusor. The Company’s pipeline programs include: scFurosemide lead product candidate, Furoscix, consists of its proprietary subcutaneous formulation of furosemide delivered via sc2Wear Infusor for diuresis in heart failure patients outside of the acute care setting. The Company has completed two pivotal clinical studies, four exploratory clinical studies, and 12 human factor studies for Furoscix, and scCeftriaxone an antibiotic used intravenously for the treatment of infections caused by gram-positive and gram-negative organisms.

Receive SCPH News and Ratings via Email

Sign-up to receive the latest news and ratings for SCPH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Delivery Systems
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:SCPH
CUSIPN/A
Phone617-517-0730

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees28
Outstanding Shares17,610,000

Scpharmaceuticals (NASDAQ:SCPH) Frequently Asked Questions

What is Scpharmaceuticals' stock symbol?

Scpharmaceuticals trades on the NASDAQ under the ticker symbol "SCPH."

Where is Scpharmaceuticals' stock going? Where will Scpharmaceuticals' stock price be in 2018?

3 analysts have issued 1 year price targets for Scpharmaceuticals' stock. Their forecasts range from $20.00 to $24.00. On average, they expect Scpharmaceuticals' stock price to reach $22.33 in the next year. View Analyst Ratings for Scpharmaceuticals.

Who are some of Scpharmaceuticals' key competitors?

Who are Scpharmaceuticals' key executives?

Scpharmaceuticals' management team includes the folowing people:

  • John H. Tucker, President, Chief Executive Officer, Director
  • Troy A. Ignelzi, Chief Financial Officer (Age 42)
  • Abraham Ceesay, Chief Operating Officer

When did Scpharmaceuticals IPO?

(SCPH) raised $96 million in an IPO on Friday, November 17th 2017. The company issued 6,400,000 shares at a price of $14.00-$16.00 per share. Jefferies, Leerink Partners and BMO Capital Markets served as the underwriters for the IPO.

When does Scpharmaceuticals' lock-up period expire?

Scpharmaceuticals' lock-up period expires on Wednesday, May 16th. Scpharmaceuticals had issued 6,400,000 shares in its IPO on November 17th. The total size of the offering was $89,600,000 based on an initial share price of $14.00. After the expiration of Scpharmaceuticals' lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted.

Who owns Scpharmaceuticals stock?

Scpharmaceuticals' stock is owned by a number of of institutional and retail investors. Top institutional investors include SUN PHARMACEUTICAL INDUSTRIES LTD (12.30%), AWM Investment Company Inc. (0.94%), Nicholas Investment Partners LP (0.70%), Bain Capital Public Equity Management LLC (0.61%), Goldman Sachs Group Inc. (0.31%) and Millennium Management LLC (0.22%). View Institutional Ownership Trends for Scpharmaceuticals.

Who bought Scpharmaceuticals stock? Who is buying Scpharmaceuticals stock?

Scpharmaceuticals' stock was bought by a variety of institutional investors in the last quarter, including AWM Investment Company Inc., Nicholas Investment Partners LP, Bain Capital Public Equity Management LLC, Goldman Sachs Group Inc., Millennium Management LLC, Bank of New York Mellon Corp and Monashee Investment Management LLC. View Insider Buying and Selling for Scpharmaceuticals.

How do I buy Scpharmaceuticals stock?

Shares of Scpharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Scpharmaceuticals' stock price today?

One share of Scpharmaceuticals stock can currently be purchased for approximately $15.35.

How big of a company is Scpharmaceuticals?

Scpharmaceuticals has a market capitalization of $270.31 million. Scpharmaceuticals employs 28 workers across the globe.

How can I contact Scpharmaceuticals?

Scpharmaceuticals' mailing address is 2400 DISTRICT AVENUE SUITE 310, BURLINGTON MA, 01830. The company can be reached via phone at 617-517-0730.


MarketBeat Community Rating for Scpharmaceuticals (SCPH)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  31 (Vote Outperform)
Underperform Votes:  21 (Vote Underperform)
Total Votes:  52
MarketBeat's community ratings are surveys of what our community members think about Scpharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Scpharmaceuticals (NASDAQ:SCPH) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyN/AN/A
Consensus Rating Score: 3.003.00N/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $22.33$22.33N/AN/A
Price Target Upside: 49.69% upside49.69% upsideN/AN/A

Scpharmaceuticals (NASDAQ:SCPH) Consensus Price Target History

Price Target History for Scpharmaceuticals (NASDAQ:SCPH)

Scpharmaceuticals (NASDAQ:SCPH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/12/2017Jefferies GroupInitiated CoverageBuy -> Buy$23.00MediumView Rating Details
12/12/2017Leerink SwannInitiated CoverageOutperform -> Outperform$20.00MediumView Rating Details
12/12/2017BMO Capital MarketsInitiated CoverageOutperform$24.00MediumView Rating Details
(Data available from 2/25/2016 forward)

Earnings

Earnings History for Scpharmaceuticals (NASDAQ:SCPH)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Scpharmaceuticals (NASDAQ:SCPH) Earnings Estimates

2018 EPS Consensus Estimate: ($2.89)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182($0.50)($0.49)($0.50)
Q2 20182($0.63)($0.50)($0.57)
Q3 20182($1.33)($0.67)($1.00)
Q4 20182($0.97)($0.69)($0.83)
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Scpharmaceuticals (NASDAQ:SCPH)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Scpharmaceuticals (NASDAQ SCPH) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 2.41%
Insider Trades by Quarter for Scpharmaceuticals (NASDAQ:SCPH)
Institutional Ownership by Quarter for Scpharmaceuticals (NASDAQ:SCPH)

Scpharmaceuticals (NASDAQ SCPH) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/21/20175Am Partners Iv, LlcMajor ShareholderBuy654,762$14.00$9,166,668.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Scpharmaceuticals (NASDAQ SCPH) News Headlines

Source:
DateHeadline
scPharmaceuticals (SCPH) Presents At Leerink Partners 7th Annual Global Healthcare Conference - SlideshowscPharmaceuticals (SCPH) Presents At Leerink Partners 7th Annual Global Healthcare Conference - Slideshow
seekingalpha.com - February 16 at 5:20 PM
 Analysts Set $22.33 Target Price for Scpharmaceuticals Inc (SCPH) Analysts Set $22.33 Target Price for Scpharmaceuticals Inc (SCPH)
www.americanbankingnews.com - February 16 at 10:28 AM
ScPharmaceuticals: Time For The PDUFA Run-UpScPharmaceuticals: Time For The PDUFA Run-Up
seekingalpha.com - February 15 at 5:23 PM
Zacks: Analysts Expect Scpharmaceuticals Inc (SCPH) to Post -$0.53 EPSZacks: Analysts Expect Scpharmaceuticals Inc (SCPH) to Post -$0.53 EPS
www.americanbankingnews.com - February 14 at 3:10 PM
Scpharmaceuticals (SCPH) Cut to "Sell" at Zacks Investment ResearchScpharmaceuticals (SCPH) Cut to "Sell" at Zacks Investment Research
www.americanbankingnews.com - February 14 at 1:46 PM
scPharmaceuticals Inc. to Present at the 7th Annual Leerink Partners Global Healthcare ConferencescPharmaceuticals Inc. to Present at the 7th Annual Leerink Partners Global Healthcare Conference
finance.yahoo.com - February 6 at 8:58 AM
Research Analysts Set Expectations for Scpharmaceuticals Incs FY2022 Earnings (SCPH)Research Analysts Set Expectations for Scpharmaceuticals Inc's FY2022 Earnings (SCPH)
www.americanbankingnews.com - January 29 at 8:50 AM
scPharmaceuticals, Inc.s Quiet Period To End  on December 27th (NASDAQ:SCPH)scPharmaceuticals, Inc.'s Quiet Period To End on December 27th (NASDAQ:SCPH)
www.americanbankingnews.com - December 20 at 1:06 AM
BMO Capital Markets Initiates Coverage on scPharmaceuticals (SCPH)BMO Capital Markets Initiates Coverage on scPharmaceuticals (SCPH)
www.americanbankingnews.com - December 18 at 12:56 AM
scPharmaceuticals (SCPH) Coverage Initiated by Analysts at Leerink SwannscPharmaceuticals (SCPH) Coverage Initiated by Analysts at Leerink Swann
www.americanbankingnews.com - December 17 at 10:44 PM
scPharmaceuticals, Inc. (SCPH) Forecasted to Earn FY2017 Earnings of ($2.23) Per SharescPharmaceuticals, Inc. (SCPH) Forecasted to Earn FY2017 Earnings of ($2.23) Per Share
www.americanbankingnews.com - December 14 at 6:50 AM
Research Analysts Offer Predictions for scPharmaceuticals, Inc.s Q3 2017 Earnings (SCPH)Research Analysts Offer Predictions for scPharmaceuticals, Inc.'s Q3 2017 Earnings (SCPH)
www.americanbankingnews.com - December 14 at 6:26 AM
scPharmaceuticals (SCPH) Now Covered by Analysts at Jefferies GroupscPharmaceuticals (SCPH) Now Covered by Analysts at Jefferies Group
www.americanbankingnews.com - December 12 at 9:04 AM
BRIEF-Ra Capital Management Reports 16.2 Percent Passive Stake In ScpharmaceuticalsBRIEF-Ra Capital Management Reports 16.2 Percent Passive Stake In Scpharmaceuticals
www.reuters.com - December 12 at 8:16 AM
scPharmaceuticals Inc. to Present at the BMO Capital Markets Prescriptions for Success Healthcare ConferencescPharmaceuticals Inc. to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference
finance.yahoo.com - December 12 at 8:16 AM
scPharmaceuticals Inc. Announces Closing of Over-Allotment Option in its Initial Public OfferingscPharmaceuticals Inc. Announces Closing of Over-Allotment Option in its Initial Public Offering
finance.yahoo.com - December 7 at 7:04 PM
scPharmaceuticals Inc. Announces Closing of Initial Public OfferingscPharmaceuticals Inc. Announces Closing of Initial Public Offering
finance.yahoo.com - November 29 at 8:11 AM
scPharmaceuticals Inc. (SCPH) Major Shareholder Purchases $9,166,668.00 in StockscPharmaceuticals Inc. (SCPH) Major Shareholder Purchases $9,166,668.00 in Stock
www.americanbankingnews.com - November 22 at 4:21 AM
IPO News This Week: A Holiday Break After Another Big WeekIPO News This Week: A Holiday Break After Another Big Week
247wallst.com - November 20 at 9:36 AM
scPharmaceuticals (SCPH) IPO Opens Fractionally Higher - StreetInsider.comscPharmaceuticals (SCPH) IPO Opens Fractionally Higher - StreetInsider.com
www.streetinsider.com - November 19 at 9:08 AM
scPharmaceuticals (SCPH) IPO Opens Fractionally HigherscPharmaceuticals (SCPH) IPO Opens Fractionally Higher
www.streetinsider.com - November 18 at 4:54 AM
scPharmaceuticals Files To Raise $100 Million In U.S. IPOscPharmaceuticals Files To Raise $100 Million In U.S. IPO
seekingalpha.com - November 17 at 8:11 AM
Injectable drug developer scPharmaceuticals prices IPO at $14 low endInjectable drug developer scPharmaceuticals prices IPO at $14 low end
www.nasdaq.com - November 17 at 8:11 AM
Food, Fashion, Finance Firms Among 10 To IPO - BenzingaFood, Fashion, Finance Firms Among 10 To IPO - Benzinga
www.benzinga.com - November 16 at 9:14 AM
scPharmaceuticals (SCPH) Announces November 17th IPOscPharmaceuticals (SCPH) Announces November 17th IPO
www.americanbankingnews.com - November 9 at 1:26 AM

SEC Filings

Scpharmaceuticals (NASDAQ:SCPH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Scpharmaceuticals (NASDAQ:SCPH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Scpharmaceuticals (NASDAQ SCPH) Stock Chart for Sunday, February, 25, 2018

Loading chart…

This page was last updated on 2/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.